Simon Rückinger

An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors

Simon Rückinger, Rüdiger von Kries, André Michael Toschke · BMC Medical Research Methodology · 2009 · 171 citations · Full text

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 131 citations · Full text

Critical Care Medicine, Clinical Infectious Disease, Anti-c5a Antibody +6

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

Simon Rückinger, Mark van der Linden, Ralf René Reinert et al. · Vaccine · 2009 · 107 citations

Vaccination, Vaccine Safety, Invasive Pneumococcal Disease +8

Prenatal and Postnatal Tobacco Exposure and Behavioral Problems in 10-Year-Old Children: Results from the GINI-plus Prospective Birth Cohort Study

Simon Rückinger, Peter Rzehak, Chih‐Mei Chen et al. · Environmental Health Perspectives · 2009 · 101 citations · Full text

Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome

Simon Rückinger, Rüdiger von Kries, Annette Siedler et al. · The Pediatric Infectious Disease Journal · 2009 · 91 citations